Bexion Pharmaceuticals Competitors and Similar CompaniesClear all
Bexion Pharmaceuticals's competitors and similar companies include Acrivon, Calidi Biotherapeutics, Day One Biopharmaceuticals and Disco Pharmaceuticals.
 Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. |  Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. |  Calidi Biotherapeutics Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer. |  Day One Biopharmaceuticals Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer. |  Disco Pharmaceuticals Disco Pharmaceuticals is a biotechnology company that specializes in cancer treatment solutions. | |
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2014 | Founding Date 2018 | Founding Date 2022 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Covington, US HQ | Locations Watertown, US HQ Lund, SE | Locations San Diego, US HQ Bernried, DE | Locations South San Francisco, US HQ | Locations Cologne, DE HQ |
Employees | Employees 274% increase | Employees 415% increase | Employees 327% increase | Employees 20 | Employees 288% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 256.1 m | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($77.9m) (FY, 2025) | Net income N/A | Net income ($107.3m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 16.6m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 8.2m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 21.7m (over 2 years ago) |
Total funding raised | Total funding raised $ 16.6m | Total funding raised N/A | Total funding raised $ 20m | Total funding raised $ 60m | Total funding raised $ 21.7m |
For sources of this data, please see the company profile
View Company Profiles
Acrivon
HQ
Watertown, US
Employees
41↑ 5% increase
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View companyCalidi Biotherapeutics
HQ
San Diego, US
Employees
32↑ 7% increase
Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.
View companyDay One Biopharmaceuticals
HQ
South San Francisco, US
Employees
20
Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer.
View companyDisco Pharmaceuticals
HQ
Cologne, DE
Employees
28↑ 8% increase
Disco Pharmaceuticals is a biotechnology company that specializes in cancer treatment solutions.
View company